section name header

Y-Site Injection Compatibility (1:1 Mixture)

Blinatumomab

(Mfr: AMG)(Conc: 0.375 mcg/mLb)

QMark

Nalbuphine HCl

(Mfr: MYL)(Conc: 1 mg/mLb)

Remarks:

Flakes transiently appear when blinatumomab is added to nalbuphine; not observed when order of mixing was reversed

Ref:

3405,3417